(Q40017366)

16 September 2017

title

Serum levels of epidermal growth factor and HER-2 neu in non small-cell lung cancer: prognostic correlation (English)

1 reference

16 September 2017

I Abdel Salam

1

1 reference

16 September 2017

H E Gaballa

series ordinal

2

1 reference

16 September 2017

N Abdel Wahab

series ordinal

3

1 reference

16 September 2017

publication date

18 December 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

26

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

161-166

1 reference

Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas

16 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12032-008-9102-Y

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12032-008-9102-Y

Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis

21 January 2018

1 reference

12 December 2020

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity

1 reference

12 December 2020

Elevated Serum c-erbB-2 Protein Levels in Patients with Pancreatic Cancer: Correlation to Metastasis and Shorter Survival

1 reference

12 December 2020

HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry

1 reference

12 December 2020

Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression

1 reference

12 December 2020

Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer

1 reference

12 December 2020

Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy

1 reference

12 December 2020

Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas

1 reference

12 December 2020

The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3

1 reference

12 December 2020

The biology of erbB-2/neu/HER-2 and its role in cancer

1 reference

12 December 2020

Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma

1 reference

12 December 2020

Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer

1 reference

12 December 2020

Quantification of free circulating DNA as a diagnostic marker in lung cancer

1 reference

12 December 2020

A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers

1 reference

12 December 2020

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

1 reference

12 December 2020

Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization

1 reference

12 December 2020

Association of HER-2 overexpression with prognosis in nonsmall cell lung carcinoma: a metaanalysis

1 reference

12 December 2020

The c-erbB-2 protein in oncogenesis: molecular structure to molecular epidemiology.

1 reference

12 December 2020

Evidence for the epidermal growth factor receptor as a target for lung cancer prevention

1 reference

12 December 2020

HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.

1 reference

12 December 2020

Do molecular markers predict survival in non-small-cell lung cancer?

1 reference

12 December 2020

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system

1 reference

12 December 2020

Epidermal growth factor receptors in lung tumours

1 reference

12 December 2020

Untangling the ErbB signalling network

1 reference

12 December 2020

Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.

1 reference

12 December 2020

Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients

1 reference

12 December 2020

Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.

1 reference

12 December 2020

Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung

1 reference

12 December 2020

Overexpression of c-erbB-2 mRNA and/or c-neu oncoprotein is a predictor for metastases from colorectal cancer

1 reference

12 December 2020

A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.

1 reference

12 December 2020

EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)

1 reference

12 December 2020

Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.

1 reference

12 December 2020

Global cancer statistics in the year 2000.

1 reference

12 December 2020

Elevated serum levels of p105(erbB-2) in patients with advanced-stage prostatic adenocarcinoma

1 reference

12 December 2020

Serologic concentrations of HER-2/neu in breast cancer patients with visceral metastases receiving trastuzumab therapy predict the clinical course

1 reference

12 December 2020

Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer

1 reference

12 December 2020

ErbB-2 protein in sera and tumors of breast cancer patients

1 reference

12 December 2020

10.1007/S12032-008-9102-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

16 September 2017

1017358273

0 references

1 reference